Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A.
von Drygalski A, Chowdary P, Kulkarni R, Susen S, Konkle BA, Oldenburg J, Matino D, Klamroth R, Weyand AC, Jimenez-Yuste V, Nogami K, Poloskey S, Winding B, Willemze A, Knobe K; XTEND-1 Trial Group. von Drygalski A, et al. Among authors: weyand ac. N Engl J Med. 2023 Jan 26;388(4):310-318. doi: 10.1056/NEJMoa2209226. N Engl J Med. 2023. PMID: 36720133 Clinical Trial.
Navigating a new terrain: how Twitter is changing hematologists.
Zaidi AU, Glaros AK, Weyand AC. Zaidi AU, et al. Among authors: weyand ac. Blood Adv. 2021 Jan 12;5(1):277-278. doi: 10.1182/bloodadvances.2020004030. Blood Adv. 2021. PMID: 33570648 Free PMC article. No abstract available.
New therapies for hemophilia.
Weyand AC, Pipe SW. Weyand AC, et al. Blood. 2019 Jan 31;133(5):389-398. doi: 10.1182/blood-2018-08-872291. Epub 2018 Dec 17. Blood. 2019. PMID: 30559264 Free article. Review.
von Willebrand disease: proposing definitions for future research.
Connell NT, James PD, Brignardello-Petersen R, Abdul-Kadir R, Ameer B, Arapshian A, Couper S, Di Paola J, Eikenboom J, Giraud N, Grow JM, Haberichter S, Jacobs-Pratt V, Konkle BA, Kouides P, Laffan M, Lavin M, Leebeek FWG, McLintock C, McRae S, Montgomery R, O'Brien SH, O'Donnell JS, Ozelo MC, Scappe N, Sidonio R, Tosetto A, Weyand AC, Kalot MA, Husainat N, Mustafa RA, Flood VH. Connell NT, et al. Among authors: weyand ac. Blood Adv. 2021 Jan 26;5(2):565-569. doi: 10.1182/bloodadvances.2020003620. Blood Adv. 2021. PMID: 33496750 Free PMC article. No abstract available.
ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.
Connell NT, Flood VH, Brignardello-Petersen R, Abdul-Kadir R, Arapshian A, Couper S, Grow JM, Kouides P, Laffan M, Lavin M, Leebeek FWG, O'Brien SH, Ozelo MC, Tosetto A, Weyand AC, James PD, Kalot MA, Husainat N, Mustafa RA. Connell NT, et al. Among authors: weyand ac. Blood Adv. 2021 Jan 12;5(1):301-325. doi: 10.1182/bloodadvances.2020003264. Blood Adv. 2021. PMID: 33570647 Free PMC article.
Gynecologic and obstetric management of women with von Willebrand disease: summary of 3 systematic reviews of the literature.
Brignardello-Petersen R, El Alayli A, Husainat N, Kalot MA, Shahid S, Aljabirii Y, Britt A, Alturkmani H, El-Khechen H, Motaghi S, Roller J, Abdul-Kadir R, Couper S, Kouides P, Lavin M, Ozelo MC, Weyand A, James PD, Connell NT, Flood VH, Mustafa RA. Brignardello-Petersen R, et al. Blood Adv. 2022 Jan 11;6(1):228-237. doi: 10.1182/bloodadvances.2021005589. Blood Adv. 2022. PMID: 34673921 Free PMC article.
Outcomes of long-term von Willebrand factor prophylaxis use in von Willebrand disease: A systematic literature review.
El Alayli A, Brignardello Petersen R, Husainat NM, Kalot MA, Aljabiri Y, Turkmani H, Britt A, El-Khechen H, Shahid S, Roller J, Motaghi S, Mansour R, Tosetto A, Abdul-Kadir R, Laffan M, Weyand A, Leebeek FWG, Arapshian A, Kouides P, James P, Connell NT, Flood VH, Mustafa RA. El Alayli A, et al. Haemophilia. 2022 May;28(3):373-387. doi: 10.1111/hae.14550. Epub 2022 Mar 26. Haemophilia. 2022. PMID: 35339117 Review.
70 results